CPT code 83021 represents a laboratory hemoglobin fractionation test performed by chromatography to measure and calculate hemoglobin fractions in whole blood. This test is clinically important for identifying and monitoring hemoglobin variants and disorders such as sickle cell disease and thalassemias, and it has national relevance given its role in diagnostic workflows and population screening programs. Payers commonly covering this service in the U.S. include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.

Readers will learn what this code denotes, the typical clinical and laboratory context for its use, and the payer landscape relevant to reimbursement and coverage discussions. The publication provides benchmarks and comparative context where available, summarizes practice and coding considerations tied to laboratory service lines, and notes areas where input data were not provided. Data not available in the input include associated taxonomies, specific ICD-10 diagnoses, related CPT or HCPCS crosswalks, and payer-specific coverage policies.